Multivariable analysis of factors predicting OS in t-ALL
| . | HR (95% CI) . | P . |
|---|---|---|
| Sex (male vs female) | 1.72 (0.95-3.12) | .07 |
| Topoisomerase II inhibitors (yes vs no) | 2 (0.97-4) | .06 |
| Radiotherapy (yes vs no) | 1.03 (0.55-2) | .92 |
| Response to first induction (CR/CRi vs refractory) | 1.72 (0.74-4.01) | .20 |
| Performance of HCT (yes vs no) | 0.41 (0.20-0.82) | .01 |
| . | HR (95% CI) . | P . |
|---|---|---|
| Sex (male vs female) | 1.72 (0.95-3.12) | .07 |
| Topoisomerase II inhibitors (yes vs no) | 2 (0.97-4) | .06 |
| Radiotherapy (yes vs no) | 1.03 (0.55-2) | .92 |
| Response to first induction (CR/CRi vs refractory) | 1.72 (0.74-4.01) | .20 |
| Performance of HCT (yes vs no) | 0.41 (0.20-0.82) | .01 |